Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Breaking Down Defenses: Autophagy as a Therapeutic Tool to Enhance Chemosensitivity in Neuroblastoma
Neuroblastoma is the most common type of cancer diagnosed in children aged between one and five years old. Diagnosed children with high-risk neuroblastoma have a 5-year survival rate of approximately 50%. Cisplatin is a commonly used treatment for high-risk neuroblastoma, unfortunately, it is often...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
AUC Knowledge Fountain
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Breaking Down Defenses: Autophagy as a Therapeutic Tool to Enhance Chemosensitivity in Neuroblastoma
- Modulators of MRP1 promoter in Neuroblastoma cell lines
- The cellular response of triple-negative breast cancer to short-term starvation: implications for chemosensitivity
- The management and outcomes of neuroblastoma in South Africa
- Molecular and cytogenetic investigations of genome aberrations in neuroblastomas
- Molecular regulation of autophagy and metastasis in breast cancer: new insights into the role of serum amyloid A
- Autophagy enhancement in 5-Aminolevulinic acid fluorescence in the treatment of gliomas